Apollo Hospitals - Public Comps and Valuation Multiples

Apollo Hospitals Overview

About Apollo Hospitals

Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.

Founded

1979

HQ

Employees

18.6K+

Website

apollohospitals.com

Sectors

Hospitals & Clinics

Financials

Last FY Revenue $2.4B

Last FY EBITDA $359M

EV

$11.9B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Apollo Hospitals Financials

See Apollo Hospitals valuation multiples based on analyst estimates

Apollo Hospitals P&L

In the most recent fiscal year, Apollo Hospitals reported revenue of $2.4B and EBITDA of $359M.

Apollo Hospitals expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Apollo Hospitals valuation multiples based on analyst estimates

	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue	XXX	$2.4B	XXX	XXX	XXX
Gross Profit	XXX	$1.1B	XXX	XXX	XXX
Gross Margin	XXX	48%	XXX	XXX	XXX
EBITDA	XXX	$359M	XXX	XXX	XXX
EBITDA Margin	XXX	15%	XXX	XXX	XXX
EBIT	XXX	$254M	XXX	XXX	XXX
EBIT Margin	XXX	11%	XXX	XXX	XXX
Net Profit	XXX	$161M	XXX	XXX	XXX
Net Margin	XXX	7%	XXX	XXX	XXX
Net Debt	XXX	$251M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Apollo Hospitals including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, Apollo Hospitals achieved $2.4B in revenue and $359M in EBITDA.
Financial Metric	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2026)	Next Fiscal Year (2027)	Two Years Forward (2028)
Total Revenue	Analyst estimates available to subscribers	$2.4B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	Analyst estimates available to subscribers	$1.1B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	Analyst estimates available to subscribers	47.6% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	Analyst estimates available to subscribers	$359M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	Analyst estimates available to subscribers	14.9% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	Analyst estimates available to subscribers	$254M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	Analyst estimates available to subscribers	10.5% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	Analyst estimates available to subscribers	$161M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	Analyst estimates available to subscribers	6.7% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	$251M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Apollo Hospitals

This financial data table provides comprehensive performance metrics for Apollo Hospitals, a company based in India. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, Apollo Hospitals reported $2.4B in total revenue.
Fiscal year EBITDA was $359M.
The company maintained a gross profit margin of 47.6% in the most recent fiscal year.
EBITDA margin for the fiscal year was 14.9%.
Net profit margin reached 6.7% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Apollo Hospitals. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Apollo Hospitals Stock Performance

Apollo Hospitals has current market cap of INR 1.03T (or $11.4B), and EV of INR 1.07T (or $11.9B).

Market Cap Evolution

Apollo Hospitals Stock Data

As of January 5, 2026, Apollo Hospitals's stock price is INR 7129 (or $79).

See Apollo Hospitals trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$11.9B	$11.4B	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Apollo Hospitals Valuation Multiples

Apollo Hospitals's trades at 5.0x EV/Revenue multiple, and 33.3x EV/EBITDA.

See valuation multiples for Apollo Hospitals and 15K+ public comps

Apollo Hospitals Financial Valuation Multiples

As of January 5, 2026, Apollo Hospitals has market cap of $11.4B and EV of $11.9B.

Equity research analysts estimate Apollo Hospitals's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Apollo Hospitals's P/E ratio is not available.

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Market cap (current)	$11.4B	XXX	$11.4B	XXX	XXX	XXX
EV (current)	$11.9B	XXX	$11.9B	XXX	XXX	XXX
EV/Revenue	n/a	XXX	5.0x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	33.3x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	47.1x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	70.9x	XXX	XXX	XXX
EV/FCF	n/a	XXX	253.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Apollo Hospitals Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Apollo Hospitals Margins & Growth Rates

Apollo Hospitals's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $48K for the same period.

Apollo Hospitals's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Apollo Hospitals's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Apollo Hospitals and other 15K+ public comps

Apollo Hospitals Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	15%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$48K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	37%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial